22Jan
Blog: Cooley’s 2020 Life Sciences M&A Year in Review
General Trends in Life Sciences M&A - If 2019 was the year of life sciences mega-deals, 2020 was the year of COVID-19, as the global pandemic permeated every aspect of the dealmaking landscape, with the life sciences sector being no exception. COVID-19 drove unprecedented levels of collaboration among biopharmaceutical companies seeking to develop a vaccine, leading to an accelerated research and development process that allowed not just one—but two—vaccines to be approved by the FDA in...
By:
Cooley LLP
Related
Dear Sir/Madam, We would like to alert you to the new rules for entering the Russian Federation thr...
Read More >
New regulations proposed by the Department of Homeland Security (DHS) are slated to take effect for ...
Read More >
Dear Retail Clients and Friends, A recent decision from the Massachusetts Supreme Judicial Court ma...
Read More >
Following in the footsteps of its neighbors Maine, Massachusetts, and New Hampshire, Rhode Island re...
Read More >
Join us for the 12th annual “Selecting Project Delivery Methods & Bidding Public Construction Contr...
Read More >
Part 1: New Labor & Employment Laws Impacting California’s Public and Private Entities - Californi...
Read More >